This inventor holds 28 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Peptide Nucleic Acids. Top assignees: Isis Pharmaceuticals, Inc., Riso National Laboratory, Boehringer Mannheim Gmbh. Active years: 1993-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fredericksberg, DK (1998 - 1999)
- DK-2000 Fredericksberg, DK (1999)
- 2960 Fungsted Kyst, DK (2000)
- DK 2960 Rungsted Kyst, DK (1996 - 2002)
- Kyst, DK (2003)
- Frederiksberg, DK (1993 - 2004)
- 2960 Rungsted Kyst, DK (2004)
- 2000 Fredericksberg, DK (2002 - 2008)
- Rungsted Kyst, DK (1997 - 2014)
Company Filing History:
3 out of 1,035 
3 out of 8 
1 out of 1,164 
Years Active: 1993-2014
Areas of Expertise:
Title: Innovations of Rolf Henrik Berg: A Pioneer in Nanotechnology and Genetics
Introduction: Rolf Henrik Berg, a distinguished innovator residing in Rungsted Kyst, Denmark, holds an impressive portfolio of 25 patents. His work primarily focuses on the development of advanced materials and compounds with applications in nanotechnology and genetic research.
Latest Patents: Among his notable patents, one of the latest is titled "Hydrophilic nanoporous materials." This patent discloses a method for preparing a nanoporous material within a polymer matrix that exhibits significant hydrophilicity. The methodology described includes the preparation of a precursor material, the removal of a portion of the first phase to form the nanoporous structure, and the irradiation of the resulting material with specific wavelengths of light in the presence of oxygen or ozone. This innovation offers potential in various applications, particularly in fields requiring specific material properties.
Another recent patent involves "Peptide nucleic acids with polyamide-containing backbones." This novel class of compounds showcases enhanced binding affinity for complementary ssDNA and RNA strands compared to standard DNA. By integrating naturally occurring DNA bases attached to a peptide backbone through suitable linkers, this innovation demonstrates significant potential in genetic research and therapeutic applications.
Career Highlights: Throughout his career, Rolf has made significant contributions to the fields of biotechnology and material science. His inventions and patents have shaped advancements in both industries. The breadth and depth of his research reflect his commitment to pushing the boundaries of innovation and technology.
Collaborations: Rolf Henrik Berg has collaborated with esteemed colleagues such as Peter Eigil Nielsen and Michael Egholm. These partnerships have fostered an environment of creativity and knowledge-sharing, leading to groundbreaking work in their respective fields.
Conclusion: Rolf Henrik Berg's work exemplifies the power of innovation in addressing complex scientific challenges. With his extensive patent portfolio and collaborative efforts, he continues to make meaningful contributions to technology and science, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile